About Us
About Us
Leadership
Leadership
Careers
Our platform
Pipeline
News
Contact
Contact
Contact
News
Filter by:
view all
press
media
publication
conference
conference
Apr 10, 2024
2024 - AACR
A click chemistry-based HER2 targeting agent activates a decoupled MMAE payload making it highly differentiated in efficacy and safety than ADCs
conference
Apr 10, 2024
2024 - AACR
Tumor targeted activation of an attenuated exatecan protodrug through Click Chemistry demonstrates efficacy in murine tumor studies
conference
Apr 10, 2024
2024 - AACR
Nectin-4 targeted therapy with MMAE protodrug results in anti-tumor efficacy mediated by click chemistry
conference
Apr 8, 2024
2024 - AACR
Click chemistry enabled selective activation of highly cytotoxic MMAE payload at tumors using TROP2 targeting agent
press
Apr 5, 2024
Press Release
Shasqi to Present Data on Novel Tumor-Targeted Drug Activation Technology at 2024 American Association for Cancer Research (AACR) Annual Meeting
conference
Mar 17, 2024
2024 - ACS
MMAE payload uncoupled from HER2 targeting agent is selectively activated at tumors through click chemistry in vivo
press
Mar 11, 2024
Press release
Shasqi Appoints Travis Biechele, Ph.D. as VP of Research to Lead Pipeline Development
press
Mar 5, 2024
Press release
Shasqi to Present New Data at 2024 World ADC London Conference
press
Jan 4, 2024
Press release
Shasqi Expands Board of Directors with Appointment of Biopharma Executives
conference
Oct 23, 2023
2023 - ESMO
Phase 1 Clinical Results of SQ3370, a Doxorubicin-based Click Chemistry Therapeutic in Advanced Solid Tumor Patients
conference
Oct 16, 2023
2023 - World ADC
MMAE payload separated from HER2 targeting agent is selectively activated at tumors through click chemistry in vivo
media
Oct 12, 2023
Drug Discovery World
Click chemistry breakthroughs drive Shasqi and J&J cancer alliance
Previous
2 / 10
Next
